Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer

Gynecologic Oncology

Volumn 131, Issue 1, 2013, Pages 99-102

  Hata, Masaharu ^a   Koike, Izumi ^a   Miyagi, Etsuko ^a   Numazaki, Reiko ^a   Asai Sato, Mikiko ^a   Kasuya, Takeo ^a   Kaizu, Hisashi ^a   Matsui, Tonika ^a   Hirahara, Fumiki ^a   Inoue, Tomio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Pelvic lymph node metastasis; Radiation therapy; Uterine cervix

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; COLITIS; COLON PERFORATION; COLON ULCER; CYSTITIS; FEMALE; FOLLOW UP; HUMAN; ILEUS; LEUKOPENIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIC LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROCTITIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; THROMBOCYTOPENIA; UTERINE CERVIX CANCER; UTERUS;

EID: 84885323773     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.07.085     Document Type: Article

References (26)

1. World Health Organization. Sexual and reproductive health. Cancer of the cervix. http://www.who.int/reproductivehealth/topics/cancers/en/index.html [Accessed in May 13, 2013].
2. Benedetti-Panici P, Maneschi F, Scambia G, Greggi S, Cutillo G, D'Andrea G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996;62: 19-24.
3. National Cancer Institute. Cervical cancer treatment. Treatment option overview. http://www.cancer.gov/cancertopics/pdq/treatment/cervical/ HealthProfessional/ page4 [Accessed in May 13, 2013].
4. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5: 649-55.
5. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105: 103-4.
6. Tod MC, Meredith WJ. A dosage system for use in the treatment of cancer of the uterine cervix. Br J Radiol 1938;11: 809-24.
7. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31: 1341-6.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-81.
9. Halperin EC, Perez CA, Brady LW. Uterine Cervix. Gynecologic Tumors. Clinical Radiation Oncology. Principle and Practice of Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
10. Toita T, KitagawaR, Hamano T, UmayaharaK,HirashimaY, Aoki Y, et al. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule. Gynecol Oncol 2012;126: 211-6.
11. Vinnicombe SJ, Norman AR, Nicolson V, Husband JE. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology 1995;194: 349-55.
12. Nicolet V, Carignan L, Bourdon F, Prosmanne O.MR imaging of cervical carcinoma: a practical staging approach. Radiographics 2000;20: 1539-49.
13. Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 1994;190: 807-11.
14. Yang WT, Lam WWM, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. Am J Roentgenol 2000;175: 759-66.
15. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995;86: 43-50.
16. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, Ihling C, Högerle S, Mix M, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001;218: 776-82.
17. Roy C, Le Bras Y, Mangold L, Saussine C, Tuchmann C, Pfleger D, et al. Small pelvic lymph node metastases: evaluation with MR imaging. Clin Radiol 1997;52: 437-40.
18. Camilien L, Gordon D, Fruchter RG,MaimanM, Boyce JG. Predictive value of computerized tomography in the presurgical evaluation of primary carcinoma of the cervix. Gynecol Oncol 1988;30: 209-15.
19. Parker K, Gallop-Evans E, Hanna L, AdamsM. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. Int J Radiat Oncol Biol Phys 2009;74: 140-6.
20. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21: 123-35.
21. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21: 109-22.
22. Jones B. Toxicity after cervical cancer treatment using radiotherapy and chemotherapy. Clin Oncol 2009;21: 56-63.
23. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358: 781-6.
24. Forrest J, Presutti J, Davidson M, Hamilton P, Kiss A, Thomas G. A dosimetric planning study comparing intensity-modulated radiotherapywith four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma. Clin Oncol 2012;24: e63-70.
25. Du XL, Tao J, Sheng XG, Lu CH, Yu H, Wang C, et al. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy. Gynecol Oncol 2012;125: 151-7.
26. Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, et al. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2011;80: 1436-45.